|Basis of Allotment|
This is a public announcement for information purposes only and is not a prospectus announcement This does not constitute an invitation or offer to acquire, purchase or subscribe for securities. Not for publication or distribution, directly or indirectly outside India.
ASTER DM HEALTHCARE LIMITED
Our Company was incorporated as DM Healthcare Private Limited on January 18, 2008 at Kochi, Ernakulam, Kerala as a private limited company under the Companies Act, 1956. The name of our Company was changed to Aster DM Healthcare Private Limited and a fresh certificate of incorporation consequent upon change of name was issued on November 29, 2013. Our Company was converted into a public limited company consequent to a special resolution passed by our Shareholders at the extraordinary general meeting held on November 10, 2014 and the name of our Company was changed to Aster DM Healthcare Limited. A fresh certificate of incorporation consequent upon conversion to public limited company was issued on January 1, 2015 For details of change in the name and registered office of our Company, see "History and Certain Corporate Matlers" on page 198 of the Prospectus dated February 17, 2018 ("Prospectus").
Registered and Corporate Office; IX/475L, Aster
Medcity, Kuttisahib Road, near Kothad Bridge, South Chittoor P.O., Cheranalloor, Kochi -
682 027. Ernakulam, Kerala, India:
OUR PROMOTERS: DR. AZAD MOOPEN AND UNION INVESTMENTS PRIVATE LIMITED
Our Company has filed the Prospectus dated February 17, 2018 with the Registrar of Companies of Kerala and Lakshadweep at Kochi and the Equity Shares are proposed to be listed on BSE Limited ("BSE") and National Stock Exchange of India Limited ("NSE") and the trading will commence on February 26, 2018.
BASIS OF ALLOTMENT
PUBLIC OFFER OF 51,586,145 EQUITY SHARES OF FACE VALUE OF RS 10 EACH ('"EQUITY SHARES") OF ASTER DM HEALTHCARE LIMITED ("COMPANY" OR "ISSUER") FOR CASH AT A PRICE OF RS 190 PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF RS 180 PER EQUITY SHARE) AGGREGATING TO RS 9.801 MILLION ("OFFER") COMPRISING A FRESH ISSUE OF 38.157,894 EQUITY SHARES AGGREGATING TO RS 7,250 MILLION ("FRESH ISSUE") AND AN OFFER FOR SALE OF 13,428,251 EQUITY SHARES BY OUR PROMOTER, UNION INVESTMENTS PRIVATE UMITED ("UIPL" OR THE "SELLING SHAREHOLDER") AGGREGATING TO RS 2,551 MILLION ("OFFER FOR SALE"). THE OFFER WILL CONSTITUTE 10.20% OF OUR POST-OFFER PAID-UP EQUITY SHARE CAPITAL
THE FACE VALUE OF THE EQUITY SHARES IS RS 10 EACH.
Risks to Investors:
The six Book Running Lead Managers associated with the Offer have handled 66 public Issues In the past three years out of which 18 public issues closed below the issues closed below the issue price as on listing date.
Average cost of acquisition for Union investments Private Lirnited is Rs 2.84 per Equity Share and offer price at upper end of the price band is Rs 190.
Weighted Average Return on Net Worth for last three full financial years based on Restated Consolidated Financial Statements is 2.10%.
In terms of Rule 19(2)(b)(iii)of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRR"), this was an Offer for at least 10% of the post-Offer paid-up equity share capital of our Company. The Offer was made in accordance with Regulation 26(1) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009, as amended (the "SEBI ICDR Regulations"), through the Book Building Process wherein 50% of the Offer was allocated on a proportionate basis to Qualified Institutional Buyers ("QIBs"), provided that our Company in consultation with the Selling Shareholder and the Managers allocated up to 60% of the QIB Portion to Anchor Investors on a discretionary basis, out of which one-third was reserved for domestic Mutual Funds only, subject to valid Bids having been received from domestic Mutual Funds at or above the Anchor Investor Offer Price, in accordance with the SEBI ICDR Regulations. 5% of the QIB Portion (excluding the Anchor Investor Portion) was available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the QIB Portion was available for allocation on a proportionate basis to all QIB Bidders (other than Anchor Investors), including Mutual Funds, subject to valid Bids having been received at or above the Offer Price. Further, not less than 15% of the Offer was available for allocation on a proportionate basis to Non-Institutional Bidders and not less than 35% of the Offer was available for allocation to Retail Individual Bidders in accordance with the SEBI ICDR Regulations, subject to valid Bids having been received at or above the Offer Price, All potential investors, other than Anchor Investors, were required to mandatorily utilise The Application Supported by Blocked Amount ("ASBA") process providing details of their respective bank accounts which was blocked by the Self Certified Syndicate Banks ("SCSBs") For details, see 'Offer Procedure' on page 599 of Prospectus.
The bidding for Anchor Investor opened and closed on February 09, 2018. The Company received 8 applications from 7 anchor investors for 15,475,902 shares The Anchor Investor Allocation Price was finalized at Rs 190 per Equity Share. A total ot 15,475,843 shares were allocated under the Anchor Investor Portion aggregating to Rs 2,940.41 Million. The Offer (excluding Anchor Investors) received 223,951 applications for 45,564,324 Equity shares (prior to technical rejections) resulting in 1.2618 times subscription. The details of the applications received in the Offer from various categories are as under (prior to technical rejections):
The Basis of Allotment was finalized in consultation with the Designated Stock Exchange, being BSE on February 21,2018.
A. Allotment to Retail Individual Investors (After Technical Rejections)
The Basis of Allotment to the Retail individual investors, who have Bid at cut-off or the Offer Pnce of Rs 190 per Equity Share was finalized In consultation with BSE. The category has been subscribed to the extent of 1.0542 times The total number of Equity Shares Allotted in this category is 19,038,277 Equity Shares (includes under subscribed portion of 983.126 Equity Shares spilled over from Non Institutional Investors Category) to 219,205 successful applicants.
The category-wise details of the Basis of Allotment are as under:
B. Allotment to Non Institutional Investors (After Technical Rejections)
The Basis of Allotment to Non Institutional Bidders, who have bid at the Offer Price of Rs 190 per Equity Share, was finalized in consultation with the BSE. This category has been subscribed to the extent of 0.6914 times. The total number of Equity Shares Allotted in this category is 5,350,332 Equity Shares to 534 successful Non- Institutional Bidder. The under subscribed portion of 2,387,590 Equity Shares in the Non Institutional Bidders category has been spilled over to Qualified Institutional Buyers and Retail Individual Investors Category in the ratio of 50:35 i.e. 1,404,464 Equity Shares to Qualified Institutional Buyers and 983,126 Equity Shares to Retail Individual Investors Category.
The category wise details of the Basis of Allotment are as under: (Sample):
C. Allotment to QIBs (After Technical Rejections)
The Basis of Allotment toQIBs, who have Bid at the Offer Price of Rs 190 per Equity Share has been done on a proportionate basis in consultation with the BSE. This category has been subscribed to the extent of 1.6736 times of QIB Portion. As per the SEBI Regulations, Mutual Funds were Allotted 5% of the Equity Shares of QlB Portion available i.e. 586,086 Equity Shares (includes under subscribed portion of 70,224 Equity Shares spilled over from Non Institutional Investprs Category) and other QIBs and unsatisfied demand of Mutual Funds were Allotted the remaining available Equity Shares i.e, 11,135,607 Equity Shares (includes under subscribed portion of 1,334.240 Equity Shares spilled over from Non Institutional Investors Category) on a proportionete basis. The total number of Equity Shares Allotted in the QIB Portion is 11,721,693 Equriy Shares (includes under subscribed portion of 1,404,464 Equity Shares spilled over from Non Institutional Investors Category), which were allotted to 7 successful QIB Bidders.
The category-wise details of the Basis of Allotment are as under:
D. Allotment to Anchor
The Company in consultation with the GCBRLMs and BRLMs has allocated 15,475,843 Equity Shares to 7 Anchor Investors who have applied through 8 applications at the Anchor investor Offer Price of Rs 190 per Equity Share in accordance with the SEBI ICDR Regulations This represents 60 % of the QIB Category.
The IPO Committee of the Company at its meeting held on February 22,2018, has noted the Basis of Allotment of the Equity Shares approved by the Designated Stock Exchange, being BSE and Allotted the Equity Shares to various successful Bidders. The Allotment advice-cum-Refund intimations are being dispatched to the address of the investors as registered with the depositories. Further, instructions to the SCSBs for unblocking of funds and tranfer to the Public Offer Account, as applicable have been issued on February 22,2018 and payment to non-Syndicate brokers have been issued on February 22,2018. The Equity Shares Allotted to the successful Applicants have been credited on February 22, 2018 to their beneficiary accounts subject to validation of the account details with the depositories concerned. In case the unblocking of funds or credit of shares is not received within ten days, investors may contact the Registrar to the Offer at the address given below. The Company had filed the Listing application with BSE and NSE on February 22, 2018. The Company has received listing and trading approval from BSE and NSE and the trading will commence on February 26, 2018.
Names of the signatories to the Memorandum of Association of our Company and the number of Equity Shares subscribed by them: Given below are the names of the signatories of the Memorandum of Association of our Company and the number of Equhy Shares subscribed by them at the time of signing of the Memorandum of Association of our Company - 5,000 Equity Shares of face value of Rs 10 each by Dr. Azad Moopen and Naseera Azad.
DISCLAIMER CLAUSE OF SECURITIES AND EXCHANGE BOARD OF INDIA ("SEBI"): SEBI only gives its observations on the offer documents and this does not constitute approval of either the offer or the specified securities or the offer document. Investors are advised to refer to page 572 of the Prospectus for the full text of the disclaimer clause of SEBI.
DISCLAIMER CLAUSE OF THE BSE (The Designated Stock Exchange); It is to be distinctly understood that the permission given by BSE should not in any way be deemed or construed that the Prospectus has been cleared or approved by BSE nor does it certify the correctness or completeness of any of the contents of the Prospectus." The investors are advised to refer to page 579 of the Prospectus for the full text of thedisclaimer clause of the BSE
DISCLAIMER CLAUSE OF THE NSE: "It is to be distinctly understood that the permission given by NSE should not in any way be deemed or construed that the offer Document has seen cleared or approved by NSE nor does it certify the correctness or completeness of any of the contents of the Offer Document." The investors are advised to refer to page 579 of the Prospectus for the full text of the disclaimer clause of the NSE.
Note: All capitalized terms used and not defined herein shall have the respective meanings assigned to them in the Prospectus.
INVESTORS PLEASE NOTE
These details of the Allotment made shall be hosted on the website of Registrar to the Offer, Link Intime India Private Limited at www.limkintime.co.in
All future correspondence in this regard may kindly be addressed to the Registrar to the Offer quoting full name of the First/ Sole applicant. Serial number of the ASBA form, nunber of Equity Shares bid for. name of the Member of the Syndicate. place where the bid was submitted and payment details at the address given below:
LINK INTIME INDIA PRIVATE LIMITED
THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF ASTER DM HEALTHCARE LIMITED